1. Bio 319: Antibiotics
Lecture Three
Topic: Inhibitors of cell wall synthesis (brief)
Inhibitors of protein biosynthesis
Lecturer: Dr. G. Kattam Maiyoh
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 1
2. Inhibitors of Cell Wall Synthesis
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 2
3. Carbapenems
• Beta-lactam ring is
fused to a 5 member
ring system
• Effect on microbes
and pharmacology
of carbapenems
similar to penicillins
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 3
4. Selected Carbapenems
• Imipenem
– Broad spectrum including anaerobes
and Pseudomonas aeruginosa
– Parentally administered
– Must be combined with cilastatin to be
absorbed
– Excreted by kidneys
• Meropenem, ertapenem, and doripenem
are similar to imipenem but don’t need co-
administration with cilastatin
cilastatin chemical compound which inhibits the human enzyme dehydropeptidase
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 4
5. Toxicity/Contraindications
of Carbapenems
• Nausea and vomiting (common)
• Hypersensitivity reactions (uncommon)
– Essentially the same as for penicillins, exception
is the monobactam
– Cross-reactivity is possible, exception is the
monobactam
GKM/BIO319:Antibiotics/Lec.
13/02/2013 5
03/Sem02/2013
6. Aztrenam – a monobactam
• Works only on Gm -ve, including Pseudomonas
aeruginosa
• Useful for treating G-ve infections that require
a beta-lactam because it does not elicit
hypersensitivity reactions
• Monobactam - beta-lactam compounds
wherein the beta-lactam ring is alone and not
fused to another ring
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 6
7. Beta-lactamase inhibitors
a. Clavulanic acid
– Irreversible inhibitor of β-lactamase
– Good oral absorption
– Combined with amoxicillin or ticarcillin
b. Sulbactam
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 7
8. Peptide Antibiotics
Peptide Antibiotics are drugs with
polypeptides structure
Sub-group of Peptide Antibiotics
Polymyxins
Glycopeptides
Bacitracin
Streptogramins
Each drug group has its own
mechanism of action
4 groups and 4 mechanism
13/02/2013
GKM/BIO319:Antibiotics/Lec.
8
03/Sem02/2013
9. • Peptide antibiotics – May be
further classified as follows;
–Polymyxins
»Polymyxin B
»Colistin
–Glycopeptides
»Vancomycin
»Teicoplanin
»Avoparcin
–Bacitracin
GKM/BIO319:Antibiotics/Lec.
13/02/2013 9
03/Sem02/2013
10. Polymyxins
Drug members
Polymyxin B
Colistin (Polymyxin E)
Mechanism of action
Detergent-like action
Damage to cell membrane function
Bind to LPS and destroy outer membrane
of Gram-negative bacteria
Bactericidal
Concentration-dependent
Non-selective on bacterial membrane
Spectrum of activity
Gram-negative bacteria
GKM/BIO319:Antibiotics/Lec.
13/02/2013 10
03/Sem02/2013
11. Polymyxins
• Pharmacokinetics
– Not absorbed via GI tract
– If injection, drug accumulated and slowly
excreted
• Toxicities
– Highly toxic if systemic injection
– Nephrotoxic
– Neurotoxic
• Clinical uses
– Oral treatment
– Local treatment
GKM/BIO319:Antibiotics/Lec.
13/02/2013 11
03/Sem02/2013
12. Glycopeptides
• Group members
– Vancomycin
• Antibacterial activity
– Inhibition of cell wall synthesis
– Active against Gram-positive bacteria
• Not absorbed orally, must administered IV
• High toxicity
– Local irritation , ototoxicity, nephrotoxicity
• Clinical uses
– Hardly used in animals
– Used only resistant case i.e. to beta-lactams
GKM/BIO319:Antibiotics/Lec.
13/02/2013 12
03/Sem02/2013
13. Bacitracin
• Only member is Bacitracin
• Drug activity
– Inhibit cell wall synthesis
– Activity on Gram-positive bacteria
– Bactericidal
• Nephrotoxic if systemic injection
• Clinical uses – the same as polymyxin
– Oral – as growth promoter
– Local or topical drugs
GKM/BIO319:Antibiotics/Lec.
13/02/2013 13
03/Sem02/2013
14. Antibiotics that Inhibit Protein Synthesis
GKM/BIO319:Antibiotics/Lec.
13/02/2013 14
03/Sem02/2013
16. Inhibition of Protein Synthesis by Antibiotics
GKM/BIO319:Antibiotics/Lec.
13/02/2013 16
03/Sem02/2013 Figure 20.4
17. Review of Initiation of Protein Synthesis
1 3
30S 2 GTP
1 2 3 GTP
Initiation Factors
f-met-tRNA
mRNA
Spectinomycin
3
GDP + Pi
50S
2
P A
1 1
2 GTP
70S Aminoglycosides
30S
Initiation Initiation
GKM/BIO319:Antibiotics/Lec.
Complex
13/02/2013
03/Sem02/2013 Complex 17
18. Review of Elongation of Protein Synthesis
P A Tetracycline P A
Tu GTP Tu GDP + Pi
GTP Ts
Ts Tu
Ts GDP
Chloramphenicol
GDP
Fusidic Acid +
GTP
G
G GDP + Pi
G GTP
P A P A
Erythromycin
GKM/BIO319:Antibiotics/Lec.
13/02/2013 18
03/Sem02/2013
20. Protein Synthesis Inhibitors
• Mostly bacteriostatic
• Selectivity due to differences in prokaryotic
and eukaryotic ribosomes
• Some toxicity - eukaryotic 70S ribosomes
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 20
21. Antimicrobials that Bind to the 30S
Ribosomal Subunit
GKM/BIO319:Antibiotics/Lec.
13/02/2013 21
03/Sem02/2013
22. a) Aminoglycosides (bactericidal)
streptomycin, kanamycin, gentamicin, tobramycin, amikacin,
netilmicin, neomycin (topical)
• Mode of action - The aminoglycosides irreversibly bind
to the 16S ribosomal RNA and freeze the 30S initiation
complex (30S-mRNA-tRNA) so that no further initiation
can occur.
• They also slow down protein synthesis that has already
initiated and induce misreading of the mRNA.
– By binding to the 16 S r-RNA the aminoglycosides increase
the affinity of the A site for t-RNA regardless of the anticodon
specificity.
• May also destabilize bacterial membranes.
GKM/BIO319:Antibiotics/Lec.
13/02/2013 22
03/Sem02/2013
23. Microbe Library
American Society for Microbiology
www.microbelibrary.org
GKM/BIO319:Antibiotics/Lec.
13/02/2013 23
03/Sem02/2013
24. b) Aminoglycosides (bactericidal)
streptomycin, kanamycin, gentamicin, tobramycin, amikacin,
netilmicin, neomycin (topical)
• Spectrum of Activity –Effective against many gram-
negative and some gram-positive bacteria;
• Not useful for anaerobic (oxygen required for uptake of
antibiotic) or intracellular bacteria.
• Resistance - Common
• Synergy - The aminoglycosides synergize with β -lactam
antibiotics. The β -lactams inhibit cell wall synthesis and
thereby increase the permeability of the aminoglycosides.
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 24
25. c) Tetracyclines (bacteriostatic)
tetracycline, minocycline and doxycycline
• Mode of action - The tetracyclines reversibly bind to the 30S
ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site
on the 70S ribosome.
• Spectrum of activity - Broad spectrum; Useful against intracellular
bacteria
• Resistance - Common
• Adverse effects - Destruction of normal intestinal flora resulting in
increased secondary infections; staining and impairment of the
structure of bone and teeth.
GKM/BIO319:Antibiotics/Lec.
13/02/2013 25
03/Sem02/2013
26. d) Spectinomycin (bacteriostatic)
• Mode of action - Spectinomycin reversibly interferes with m-RNA
interaction with the 30S ribosome. It is structurally similar to the
aminoglycosides but does not cause misreading of mRNA.
• Spectrum of activity - Used in the treatment of penicillin-resistant
Neisseria gonorrhoeae
• Resistance - Rare in Neisseria gonorrhoeae
GKM/BIO319:Antibiotics/Lec.
13/02/2013 26
03/Sem02/2013
27. Antimicrobials that Bind to the 50S
Ribosomal Subunit
GKM/BIO319:Antibiotics/Lec.
13/02/2013 27
03/Sem02/2013
28. a) Chloramphenicol, Lincomycin,
Clindamycin (bacteriostatic)
• Mode of action - These antimicrobials bind to the 50S ribosome and
inhibit peptidyl transferase activity.
• Spectrum of activity - Chloramphenicol - Broad range;
Lincomycin and clindamycin - Restricted range
• Resistance - Common
• Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but
is used in the treatment of bacterial meningitis.
GKM/BIO319:Antibiotics/Lec.
13/02/2013 28
03/Sem02/2013
29. b) Macrolides (bacteriostatic)
erythromycin, clarithromycin, azithromycin, spiramycin
• Mode of action - The macrolides inhibit translocation.
• Spectrum of activity - Gram-positive bacteria,
Mycoplasma, Legionella
• Resistance - Common
GKM/BIO319:Antibiotics/Lec.
13/02/2013 29
03/Sem02/2013
30. Macrolides : Classification
• Macrolides are drugs with lactone ring
structure
• Sub-groups are based on no. of ring atom
– 12-membered ring macrolides
– 13-membered
– 14-membered (many drugs)
– 15-membered
– 16-membered (many drugs)
• Special groups
– Azalides – name for 15-membered
– Triamilides – name for tulathromycin
(combination of 13- and 15-membered)
– Ketolides – name for 14-membered with 3
keto group
32. Macrolides – general
properties
• Mechanism of
action
– Inhibit protein
synthesis
– Bind to 50S
ribosomal unit
– Bacteriostatic
• Spectrum of
activity
– Gram-positive
– Some Gram-
negative
34. Macrolides
Additional properties
of Macrolides
• Anti-inflammatory
effect
– Inhibitory effect on
neutrophils
– inhibit
proinflammatory
cytokines
– Useful for treatment
of inflammatory
35. Erythromycin
• Erythromycin is a standard or basic drug of
macrolides
• Other drug members are usually compared
with erythromycin
• Important adverse effect - severe diarrhea
– Especially in adult horse and ruminants
• Clinical uses
– Second choice (alternative drug)
– Small animals
– Fowls
– Some cases in ruminants
– Not used in pigs
36. Tylosin and Spiramycin
• Tylosin and Spiramycin
– Activities are similar
to erythromycin
– Good activity on
Mycoplasma
• Clinical uses
– Macrolides used in
ruminants and pigs
– Used for Mycoplasma
infection
37. Advanced generation
Macrolides
Example drugs
Roxithromycin
Dirithromycin
Clarithromycin
Azithromycin
General activity – the same as erythromycin
Better Pharmacokinetic properties
Acid stable
Fewer GI side effect
Higher oral availability
Longer serum half-lives
Higher tissue concentrations
38. Ketolides
• Ketolides are 14-
membered ring
macrolides with 3
keto group
• Specific drugs
– Telithromycin
– Cethromycin (still
in clinical study)
• Important
properties
– Less resistance
– Good activities on
39. Antimicrobials that Interfere with
Elongation Factors
Selectivity due to differences in prokaryotic and eukaryotic
elongation factors
GKM/BIO319:Antibiotics/Lec.
13/02/2013 39
03/Sem02/2013
40. Fusidic acid (bacteriostatic)
• Mode of action - Fusidic acid binds to elongation factor G (EF-G) and
inhibits release of EF-G from the EF-G/GDP complex.
• Spectrum of activity - Gram-positive cocci
13/02/2013 GKM/BIO319:Antibiotics/Lec. 03/Sem02/2013 40